The G20 Health & Development Partnership (G20 HDP) is an advocacy organisation that aims to ensure that G20 countries are coordinating their health innovation strategy to tackle the growing burden of communicable and non-communicable diseases globally to promote the delivery of SDG 3. The Partnership emerged as an informal coalition of like-minded organisations during the G20 Presidency in Germany in 2017 respecting the objectives of SDG 17. Following broad interest to build on the initiative leading up to the Argentinian G20 Presidency in 2018, Sovereign Sustainability and Development (SSD) was created in late 2017 to act as the secretariat of the Partnership. During a working session in the UK Houses of Parliament in December 2017, with the support of the founding organisations, the G20 HDP was formally launched. The Partnership comprises of 16 cross-sectoral partners including product development partnerships, non-for-profit and international organisations, public-private partnerships, pharmaceuticals, associations, research institutes and academia.
Following the Health20 event in the sidelines of the World Health Assembly in Geneva, the G20 HDP has jointly drafted several recommendations in a Report in which the Partnership urged the G20 Heads of Government, Health and Finance Ministers to incentivise innovation in health research and development (R&D) and delivery.
With the support of 21 leading global organisations, representing more than 1000 collaborators, the Partnership produced the Healthy Nations – Sustainable Economies Report. This report has been prepared for the G20 troika of Argentina, Japan and Saudi Arabia by including Germany in its focus point based on its successful presidency championing health in 2017. The case studies in this report convincingly exemplify that through coordinated, innovative and sustained investment and cross-sectoral partnership models, further significant progress can be made within the timeframe of the United Nations Sustainable Development Goals.
The Partnership aims to highlight that underinvestment in measures to tackle the disease burden and improve health within the G20 is seriously impairing growth and economic performance and presents major long-term challenges for public budgets. The Partnership aims to elevate health permanently on the agendas of finance ministers and heads of governments during the G20 Presidency. The Partnership promotes existing and new models for innovative and blended forms of financing that have been most successful and that significantly supplement funds that are currently provided by the governments, the private sector and philanthropic organisations. The Partnership believes that global health challenges need to be treated with the same importance and urgency as climate change.
The Partnership aims to elevate the need for timely action in combatting some of the most pressing health challenges of our times on to higher political agendas of the G20, but also on the international agendas including the UN, WHO, AU, the Commonwealth, and the International Organisation of the Francophonie. Current and future health challenges need to be discussed beyond G20 Health Ministers and put to the attention of G20 Finance Ministers and G20 Heads of State.
As the G20 continue its focus on areas on health security, including the response to antimicrobial resistance (AMR) and health emergency response, health systems strengthening and universal health coverage, the Partnership will seek to add value to these areas of prioritisation and drive political support. The Partnership aims to align with the WHO’s 13th General Programme of Work and supports the WHO’s Global Action Plan on Sustainable Development Goals by maintaining a focus on the Accelerators and the broader innovation ecosystem. In 2019, the Partnership will organise a series of events including the recently launched report “Healthy Nations – Sustainable Economies Report” in the UK Parliament on 5th March 2019 and a Health20 event in Tokyo on 24th June 2019 that coincides with the G20 Summit and the first Joint Health and Finance
Ministers’ Meeting focusing on global health innovation for R&D and Delivery and innovative and blended forms of innovative financing for health.
The Partnership can set in motion steps to examine new ways of funding innovation in health and encourage the establishment of existing and new mechanisms that will help to fund the diagnostics, vaccines and medicines and delivery systems that are so urgently required globally. Investment in health innovation and delivery produces significant returns, including improvements in sustainable economic growth.
Mission: To mobilize the means required to meet the UN Sustainable Development Goals by 2030 through catalytic action that secures political, intellectual, social and economic capital.
Vision: To break existing silos between health and finance ministers and between the health community to promote cross-sectoral global partnerships for Sustainable Development where the power of people, organisations and technology is harnessed to guarantee healthy nations, sustainable & wealthier economies.
Strategic objective: to convene global health stakeholders – public-private partnerships, research institutes, international organisations, public sector entities, politicians, philanthropies, think tanks and the private sector (i.e. non-traditional actors) to;
- Advocate for inclusive and output-driven partnerships aligned with SDG 3 & 17 that advance innovation in health in its widest sense and that create value to deliver solutions to the most pressing challenges of the 21st century;
- Replicate and accelerate the scale up of current best-practice models to secure political support and sustainable diversiﬁed funding for increased cross-sectoral collaboration to tackle imminent global health challenges.